Clear 618 Results Filter Filter Results Type: Product Impella 55® Type: Press Release TCT 2022 Impella® Enables Complete Revascularization Improved Quality of Life and Native Heart Recovery Type: Press Release FDA Approves RECOVER IV Randomized Controlled Trial with Exception from Informed Consent (EFIC) Type: Press Release Unloading with Impella® for 30 Minutes Before PCI Associated with Reduced Infarct Size in STEMI Patients Type: Press Release Large Multi-Center Multi-Society Study of Impella-supported Patients Finds 30-day AMI Cardiogenic Shock Survival of 81% Type: Press Release Multi-Center Multi-Society Study of Impella®-Supported Patients with Cardiogenic Shock due to Myocarditis in Japan Achieves 30-day Survival of 77% Type: Press Release Yale University Study Demonstrates Significant Survival Benefit in High-Risk PCI with Impella Support Type: Press Release US FDA Grants 510(k) Clearance for Impella Low Profile Sheath Type: Press Release Abiomed Successfully Completes All Impella Post-Approval Studies for High-Risk PCI Cardiogenic Shock Post-Cardiotomy Cardiogenic Shock and Right Heart Failure Type: Press Release Abiomed Creates Patient Assistance Program to Address Disparities in Healthcare 1 2 3 4 …
